< Return to trials

Low Sexual Desire

Overview

Lillestol Research has performed multiple trials involving the hypoactive sexual sesire sisorder (HSDD), also known as low sexual desire, indication/diagnosis. The trials have varied in phase, enrollment criteria and trial duration. HSDD is one of our most experienced trial indications to recruit to. The multitude of trials that we have performed in this indication has developed a robust research patient database of over 800 individuals with a HSDD diagnosis that would be interested in clinical trial participation.


Spotlight Trial(s)

  1. This was an investigational product, placebo-controlled trial evaluating IP in the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women. Lillestol Research was a top enroller on this trial. Our site was able to successfully meet and far exceed the sponsor’s enrollment expectation randomizing 63 patients to the trial.
  2. This was an investigational product, placebo-controlled trial evaluating IP in the treatment of hypoactive sexual desire disorder (HSDD) in surgically menopausal women. Lillestol Research was able to successfully meet and exceed the sponsor’s enrollment expectation randomizing 11 patients to the trial.
  3. This was an investigational product, placebo-controlled trial evaluating IP in the treatment of hypoactive sexual desire disorder (HSDD) in naturally postmenopausal women. Lillestol Research was able to successfully meet and exceed the sponsor’s enrollment expectation randomizing 12 patients in an 8-month enrollment period.

If you are bothered by low sexual desire, contact us today to learn more about our current study opportunities for this diagnosis.

Call us at (701) 232-7705 or toll-free at (866) 532-7705.

Signup online at https://www.lillestolresearch.com/sign-up or email our recruiter at recruiter(at)lillestolresearch(dot)com.

Your information is always kept confidential.